The Pharmacology and Toxicology of Atypical Antipsychotic Agents

REFERENCES

• Borison R. L. Recent Advances in the Pharmacotherapy of Schizophrenia. Harvard Rev. Psychiatry 1997; 4: 255–271
   PubMed Web of Science ®Google Scholar
• Tandon R., Milner K., Jibson M. D. Antipsychotics from Theory to Practice: Integrating Clinical and Basic Data. J. Clin. Psychiatry 1999; 60: 21–28
   PubMed Web of Science ®Google Scholar
• Brown C. S., Markowitz J. S., Moore T. R., Parker N. G. Atypical Antipsychotics: Part II: Adverse Effects, Drug Interactions, and Costs. Ann. Pharmacother. 1999; 33: 210–217
   PubMed Web of Science ®Google Scholar
• Weiden P., Aquila R., Standard J. Atypical Antipsychotic Drugs and Long-Term Outcome in Schizophrenia. J. Clin. Psychiatry 1996; 57: 53–60
   PubMed Web of Science ®Google Scholar
• Richelson E. Receptor Pharmacology of Neuroleptics: Relation to Clinical Effects. J. Clin. Psychiatry 1999; 60: 5–14
   PubMed Web of Science ®Google Scholar
• Jibson M. D., Tandon R. New Atypical Antipsychotic Medications. J. Psychiatric Research 1998; 32: 215–228
   PubMed Web of Science ®Google Scholar
• Blin O. A Comparative Review of New Antipsychotics. Can. J. Psychiatry 1999; 44: 235–244
   PubMed Web of Science ®Google Scholar
• Kinon B. J., Lieberman J. A. Mechanisms of Action of Atypical Antipsychotic Drugs: A Critical Analysis. Psychopharmacology 1996; 124: 2–34
   PubMed Web of Science ®Google Scholar
• Farde L., Nordstrom A. L., Wiesel G. A., Wiesel F. A., Pauli S., Halldin C., Sedvall G. Positron Emission Tomographic Analysis of Central D1and D2Dopamine Receptor Occupancy in Patients Treated with Classical Neuroleptics and Clozapine: Relation to Extrapyramidal Side Effects. Arch. Gen. Psychiatry 1992; 49: 538–544
   PubMed Web of Science ®Google Scholar
• Lieberman J. A., Mailman R. B., Duncan G., Sikich L., Chakos M., Nichols D. E., Kraus J. E. Serotonergic Basis of Antipsychotic Drug Effects in Schizophrenia. Biol. Psychiatry 1998; 44: 1099–1117
   PubMed Web of Science ®Google Scholar
• Gerlach J., Peacock L. New Antipsychotics: The Pres-ent Status. Int. Clin. Psychopharmacol. 1995; 10: 39–48
   PubMed Web of Science ®Google Scholar
• Baldessarini R. J. Drugs and the Treatment of Psychiatric Disorders: Psychosis and Anxiety. Goodman & Gilman's Pharmacological Basis of Therapeutics, J. G. Hardman, L. E. Limbird, P. B. Molinoff, R. W. Ruddon, A. G. Gilman. 9th Edn., McGraw-Hill, New York 1996; 399–430
   Google Scholar
• Seeman P., Lee T., Chau-Wong M., Wong K. Antipsychotic Drug Doses and Neuroleptic Dopamine Receptors. Nature 1976; 261: 717–719
   PubMed Web of Science ®Google Scholar
• Risch S. C. Pathophysiology of Schizophrenia and the Role of Newer Antipsychotics. Pharmacotherapy 1996; 16: 11–14
   PubMedGoogle Scholar
• Black J. L., Richelson E. Antipsychotic Drugs: Prediction of Side Effect Profiles Based on Neuroreceptor Data Derived from Human Brain Tissue. Mayo Clin. Proc. 1987; 62: 369–372
   PubMed Web of Science ®Google Scholar
• Kapur S., Remington G. Serotonin-Dopamine Interaction and Its Relevance to Schizophrenia. Am. J. Psychiatry 1996; 153: 466–476
   PubMed Web of Science ®Google Scholar
• Snyder S., Greenberg D., Yamamura J. I. Antischizophrenic Drugs and Brain Cholinergic Receptors: Affinity for Muscarinic Sites Predicts Extrapyramidal Effects. Arch. Gen. Psychiatry 1974; 31: 58–61
   PubMed Web of Science ®Google Scholar
• Warner J. P., Barnes T. R.E., Henry J. A. Electrocardiographic Changes in Patients Receiving Neuroleptic Medication. Acta. Psychiar. Scand. 1996; 93: 311–313
   PubMed Web of Science ®Google Scholar
• Gajwani P., Pozuelo L., Tesar G. E. QT Interval Prolongation Associated with Quetiapine (Seroquel) Overdose. Psychosomatics 2000; 41: 63–65
   PubMed Web of Science ®Google Scholar
• Lee A. M., Knoll J. L., Suppes R. The Atypical Antipsychotic Sertindole: A Case Series. J. Clin. Psychiatry 1997; 58: 410–416
   PubMed Web of Science ®Google Scholar
• Brown K., Levy H., Brenner C., Leffler S., Hamburg E. L. Overdose of Risperidone. Ann. Emerg. Med. 1993; 22: 1908–1910
   PubMed Web of Science ®Google Scholar
• Hustey F. M. Acute Quetiapine Poisoning. J. Emerg. Med. 1999; 17: 995–997
   PubMed Web of Science ®Google Scholar
• Duenas-Laita A., Castro-Villamor M. A., Martin-Escudero J. C., Perez-Castrillon J. L. New Clinical Manifestations of Acute Risperidone Poisoning (letter). J. Toxicol. Clin. Toxicol. 1999; 37: 893–894
   PubMedGoogle Scholar
• Drici M. D., Wang W. X., Liu X. K., Woosley R. L., Flockhart D. A. Prolongation of QT Interval in Isolated Feline Hearts by Antipsychotic Drugs. J. Psychopharmacol. 1998; 18: 477–481
   Web of Science ®Google Scholar
• Rampe D., Murawsky K., Grau J., Lewis E. W. The Antipsychotic Agent Sertindole is a High Affinity Antagonist of the Human Cardiac Potassium Channel HERG. J. Pharm. Exp. Ther. 1998; 286: 788–793
   PubMed Web of Science ®Google Scholar
• Cold J. A., Wells B. G., Froemming J. H. Seizure Activity Associated with Antipsychotic Therapy. DICP 1990; 24: 601–606
   PubMedGoogle Scholar
• Devinsky D., Honigfeld G., Patin J. Clozapine-Related Seizures. Neurology 1991; 41: 369–371
   PubMed Web of Science ®Google Scholar
• Alldredge B. K. Seizure Risk Associated with Psychotropic Drugs: Clinical and Pharmacokinetic Considerations. Neurology 1999; 53: S68–S75
   PubMed Web of Science ®Google Scholar
• Ereshefsky L. Pharmacokinetics and Drug Interactions: Update for New Antipsychotics. J. Clin. Psychiatry 1996; 57: 12–25
   PubMed Web of Science ®Google Scholar
• Markowitz J. S., Brown C. S., Moore T. R. Atypical Antipsychotics Part I: Pharmacology, Pharmacokinetics, and Efficacy. Ann. Pharmacother. 1999; 33: 73–85
   PubMed Web of Science ®Google Scholar
• Bever K. A., Perry P. J. Olanzapine: A Serotonin-Dopamine-Receptor Antagonist for Antipsychotic Therapy. Am. J. Health-Syst. Pharm. 1998; 55: 1003–1016
   PubMed Web of Science ®Google Scholar
• Goren J. L., Levin G. M. Quetiapine, An Atypical Antipsychotic. Pharmacotherapy 1998; 18: 1183–1194
   PubMed Web of Science ®Google Scholar
• Jann M., Grimsley S., Gray E., Chang W. Pharmacokinetics and Pharmacodynamics of Clozapine. Clin. Pharmacokinet. 1993; 24: 161–176
   PubMed Web of Science ®Google Scholar
• Byerly M. J., DeVane C. L. Pharmacokinetics of Clozapine and Risperidone: A Review of Recent Literature. J. Clin. Psychopharmacol. 1996; 16: 177–187
   PubMed Web of Science ®Google Scholar
• Fang J., Gorrod J. W. Metabolism, Pharmacogenetics, and Metabolic Drug-Drug Interactions of Antipsychotic Drugs. Cellular Molec. Neurobiology 1999; 19: 491–510
   PubMed Web of Science ®Google Scholar
• Litovitz T. L., Klein-Schwartz W., Caravati E. M., Youniss J., Crouch B., Lee S. 1998 Annual Report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am. J. Emerg. Med. 1999; 17: 435–487
   PubMed Web of Science ®Google Scholar
• Mowry J., Sanftleben J., Smith J. Eighteen Month Retrospective Evaluation of Seroquel Exposures (abstract). J. Toxicol. Clin. Toxicol. 1999; 37: 631
   Google Scholar
• LeBlaye I., Donatini B., Hall M., Krupp P. Acute Overdosage with Clozapine: A Review of the Available Clinical Experience. Pharmaceutical. Med. 1992; 6: 169–178
   Google Scholar
• Elian A. A. Fatal Overdose of Olanzepine. Forensic Sci. International 1998; 91: 231–235
   PubMed Web of Science ®Google Scholar
• Stephens B. G., Coleman D. E., Baselt R. C. Olanzapine-Related Fatality. J. Forensic Sci. 1998; 43: 1252–1253
   PubMed Web of Science ®Google Scholar
• Reith D., Monteleone P. R., Whyte I. M., Ebelling W., Holford N. H., Carter G. L. Features and Toxicokinetics of Clozapine in Overdose. Ther. Drug Mon. 1998; 20: 92–97
   PubMed Web of Science ®Google Scholar
• Yip L., Dart R. C., Graham K. Olanzapine Toxicity in a Toddler (letter). Pediatrics 1998; 102: 1494
   PubMed Web of Science ®Google Scholar
• Bond G. R., Thompson J. D. Olanzapine Pediatric Overdose (letter). Ann. Emerg. Med. 1999; 34: 292–293
   PubMed Web of Science ®Google Scholar
• Mady S., Wax P., Wang D., Goetz C., Hadley C., Love R. Pediatric Clozapine Intoxication. Am. J. Emerg. Med. 1996; 14: 462–463
   PubMed Web of Science ®Google Scholar
• Cheslik T. A., Erramouspe J. Extrapyramidal Symptoms Following Accidental Ingestion of Risperidone in a Child. Ann. Pharmacotherapy 1996; 30: 360–363
   PubMed Web of Science ®Google Scholar
• Warden C. R., Pace S. A. Clozapine Overdose in a Child Presenting with Acute Respiratory Arrest (abstract). J. Toxicol. Clin. Toxicol. 1996; 34: 571
   Google Scholar
• Gesell L. B. Toxicity Following a Single Dose of Risperidone for Pediatric Attention Deficit Hyperactivity Disorder (ADHD) [abstract]. J. Toxicol. Clin. Toxicol. 1997; 35: 549
   Google Scholar
• Meeker J. E., Herrmann P. W., Som S. W., Reynolds P. C. Clozapine Tissue Concentrations Following an Apparent Suicidal Overdose of Clozaril®. J. Anal. Toxicol. 1992; 16: 54–56
   PubMed Web of Science ®Google Scholar
• Springfield A. C., Bodiford E. An Overdose of Risperidone. J. Anal. Toxicol. 1996; 20: 202–203
   PubMed Web of Science ®Google Scholar
• Gardner D. M., Milliken J., Dursun S. M. Olanzapine Overdose (letter). Am. J. Psychiatry 1999; 156: 1118–1119
   PubMed Web of Science ®Google Scholar
• Harmon T. J., Benitez J. G., Krenzelok E. P., Cortes-Belen E. Loss of Consciousness from Acute Quetiapine Overdosage. J. Toxicol. Clin. Toxicol. 1998; 36: 599–602
   PubMed Web of Science ®Google Scholar
• Janssen Pharmaceuticals. Product Information: Risperdal (Risperidone). Physicians' Desk Reference. 54th Edn., Medical Economics Company, Montvale, New Jersey 2000; 1453–1457
   Google Scholar
• Schuster P., Gabriel E., Luefferie B., Gabriel E., Kufferle B., Strobl G., Karobath M. Reversal by Physostigmine of Clozapine-Induced Delirium. Clin. Toxicol. 1977; 10: 437–441
   PubMed Web of Science ®Google Scholar
• Ishii A., Mizoguchi K., Kageoka M., Seno H., Kumazawa T., Suzuki O. Nonfatal Suicidal Intoxication by Clozapine. J. Toxicol. Clin. Toxicol. 1997; 35: 195–197
   PubMed Web of Science ®Google Scholar
• Ines S., Mahal A., Hoss J., Gaertner H. J. Intoxication with Clozapine: Plasma Levels Above 9000 ng/mL. Typical Clinical Picture—Diagnostic Confusion (abstract). Neuropsychopharmacol. 1994; 10: 122S
   Google Scholar
• Levinson B. Clozapine (Leponex) Overdosage (letter). South Afr. Med. J. 1975; 4: 5
   Google Scholar
• Worm K., Kringsholm B., Steentoft A. Clozapine Cases with Fatal, Toxic or Therapeutic Concentrations. Int. J. Leg. Med. 1993; 106: 115–118
   PubMed Web of Science ®Google Scholar
• Bedry R., Deschamps L., Pehourcq F., Moore N., Pillet O., Favarel-Garrigues J. C. Non-fatal Clozapine (Leponex) Intoxication with Toxicokinetic Evaluation. Vet. Human Toxicol. 1999; 41: 20–22
   PubMedGoogle Scholar
• Wolf L. R., Otten E. J. A Case Report of Clozapine Overdose (abstract). Vet. Human Toxicol. 1991; 33: 370
   Google Scholar
• Broich K., Heinrich S., Marneros A. Acute Clozapine Overdose: Plasma Concentration and Outcome. Pharmacopsychiat. 1998; 31: 149–151
   PubMed Web of Science ®Google Scholar
• Roy D. M., Cutten A. E.C. Clozapine Overdose with Pronounced Neutrophilia: A Case Report (letter). Aust. & N. Zealand J. Psychiatr. 1993; 27: 530–531
   PubMed Web of Science ®Google Scholar
• Welber M. R., Nevins S. Clozapine Overdose: A Case Report. J. Emerg. Med. 1995; 13: 199–202
   PubMedGoogle Scholar
• Hagg S., Spigset O., Edwardsson H., Bjork H. Prolonged Sedation and Slowly Decreasing Clozapine Serum Concentrations After an Overdose (letter). J. Clin. Psychopharmacol. 1999; 19: 282–284
   PubMed Web of Science ®Google Scholar
• Stevens I., Gaertner H. J. Plasma Level Measurement in a Patient with Clozapine Intoxication (letter). J. Clin. Psychopharmacol. 1996; 16: 86–87
   PubMed Web of Science ®Google Scholar
• Piccini G., Ceroni P., Marchesi C., Maggini C. Acute Clozapine Overdosage (letter). Br J. Psychiatr. 1997; 170: 290
   PubMed Web of Science ®Google Scholar
• Fogel J., Diaz J. E. Olanzapine Overdose (letter). Ann. Emerg. Med. 1998; 32: 275–276
   PubMed Web of Science ®Google Scholar
• Chambers R. A., Caracansi A., Weiss G. Olanzapine Overdose Cause of Acute Extrapyramidal Symptoms (letter). Am. J. Psychiatr. 1998; 155: 1630–1631
   PubMed Web of Science ®Google Scholar
• O'Malley G. F., Seifert S., Heard K., Daly F., Dart R. C. Olanzapine Overdose Mimicking Opioid Intoxication. Ann. Emerg. Med. 1999; 34: 279–281
   PubMed Web of Science ®Google Scholar
• Bonin M. M., Burkhart K. K. Olanzapine Overdose in a 1-Year Old Male. Ped. Emerg. Care 1999; 15: 266–267
   PubMed Web of Science ®Google Scholar
• Cohen L. G., Fatalo A., Thompson B. T., Di Centes Bergeron G., Flood F. G., Poupolo P. R. Olanzapine Overdose with Serum Concentrations. Ann. Emerg. Med. 1999; 34: 275–278
   PubMed Web of Science ®Google Scholar
• Dougherty T. J., Greene T. F., Farrell S. E., Roberts J. R. Adult and Pediatric Olanzapine (Zyprexa®) Overdose (abstract). J. Toxicol. Clin. Toxicol. 1997; 35: 550
   Google Scholar
• Powell G., Nelson L., Hoffman R. Overdose with Olanzapine (Zyprexa®), A New Antipsychotic Agent (abstract). J. Toxicol. Clin. Toxicol. 1997; 35: 550
   Google Scholar
• Nudelman E., Vinuela L. M., Cohen C. I. Safety in Overdose of Quetiapine: A Case Report (letter). J. Clin. Psychiatry 1998; 59: 433
   PubMed Web of Science ®Google Scholar
• Lynch S., Fill S., Hoffman R. S. Intentional Quetiapine (Seroquel) Overdose (abstract). J. Toxicol. Clin. Toxicol. 1999; 37: 631
   Google Scholar
• Lee H. S., Tan C. H., Au L. S.Y., Khoo Y. M. Serum and Urine Risperidone Concentrations in Acute Overdose (letter). J. Clin. Psychopharmacol. 1997; 17: 325–326
   PubMed Web of Science ®Google Scholar
• Acri A. A., Henretig F. M. Effects of Risperidone in Overdose. Am. J. Emerg. Med. 1998; 16: 498–501
   PubMed Web of Science ®Google Scholar
• Kopala L. C., Day C., Dillman B., Gardner D. A Case of Risperidone Overdose in Early Schizophrenia: A Review of Potential Complications. J. Psychiatry Neurosci. 1998; 23: 305–308
   PubMed Web of Science ®Google Scholar
• Kuspis D., Dean B., Krenzelok E. P. Risperidone Overdose Assessment (abstract). J. Toxicol. Clin. Toxicol. 1995; 33: 552
   Google Scholar
• Catalano F., Catalano M. C., Taylor W. Acute Risperidone Overdose. Clin. Neuropharmacol. 1997; 20: 82–85
   PubMed Web of Science ®Google Scholar
• Heather G. S., Vicas I. M.O. Risperidone Overdose: A Case Series (abstract). Vet. Human Toxicol. 1994; 36: 371
   Google Scholar
• Himstreet J. E., Daya M. Hypotension and Orthostasis Following a Risperidone Overdose (letter). Ann. Pharmacother. 1998; 32: 267
   PubMed Web of Science ®Google Scholar
• Moore N. C., Shukla P. Risperidone Overdose. Am. J. Psychiatr. 1997; 154: 289–290
   PubMed Web of Science ®Google Scholar
• Lo Vecchio F., Hamilton R. J., Hoffman R. J. Risperidone Overdose (letter). Am. J. Emerg. Med. 1996; 14: 95–96
   PubMed Web of Science ®Google Scholar
• Novartis Pharmaceuticals. Product Information: Clozaril (Clozapine). Physicians' Desk Reference. 54th Edn., Medical Economics Company, Montvale, New Jersey 2000; 2008–2012
   Google Scholar
• Eli Lilly Industries. Product Information: Zyprexa (Olanzapine). Physicians' Desk Reference. 54th Edn., Medical Economics Company, Montvale, New Jersey 2000; 1649–1653
   Google Scholar
• Zeneca Pharmaceuticals. Product Information: Seroquel (Quetiapine). Physicians' Desk Reference. 54th Edn., Medical Economics Company, Montvale, New Jersey 2000; 562–566
   Google Scholar
• Reilly J. G., Ayis S. A., Ferrier I. N., Jones S. J., Thomas S. H. QTc-Interval Abnormalities and Psychotropic Drug Therapy in Psychiatric Patients. Lancet 2000; 355: 1048–1052
   PubMed Web of Science ®Google Scholar
• Renwick A. C., Renwick A. G., Flanagan R. J., Ferner R. E. Monitoring of Clozapine and Norclozapine Plasma Concentration-Time Curves in Acute Overdose. J. Toxicol. Clin. Toxicol. 2000; 38: 325–328
   PubMed Web of Science ®Google Scholar
• Ravin D. S., Levenson J. W. Fatal Cardiac Event Following Initiation of Risperidone Therapy. Ann. Pharmacother. 1997; 31: 867–870
   PubMed Web of Science ®Google Scholar
• Tamminga C. A. The Promise of New Drugs for Schizophrenia Treatment. Can. J. Psychiatry 1997; 42: 265–273
   PubMed Web of Science ®Google Scholar
• Jibson M. D., Tandon R. A Summary of Research Findings on the New Antipsychotic Drugs. Essent. Psychopharmacol. 1996; 1: 27–37
   Google Scholar
• Casey D. The Relationship of Pharmacology to Side Effects. J. Clin. Psychiatry 1997; 58(Suppl 10)55–62
   PubMed Web of Science ®Google Scholar
• Cortese L., Pourcher-Bouchard E., Williams R. Assessment and Management of Antipsychotic-Induced Adverse Events. Can. J. Psychiatry 1998; 43(1)15S–20S
   Google Scholar
• Karagianis J. L., Phillips L. C., Hogan K. P., LeDrew K. K. Clozapine-Associated Neuroleptic Malignant Syndrome: Two New Cases and a Review of the Literature. Ann. Pharmacother. 1999; 33: 623–630
   PubMed Web of Science ®Google Scholar
• Levin G. M., Lazowick A. L., Powell H. S. Neuroleptic Malignant Syndrome with Risperidone. J. Clin. Psychopharmacol. 1996; 16: 192–193
   PubMed Web of Science ®Google Scholar
• Gleason P. P., Conigliaro R. L. Neuroleptic Malignant Syndrome with Risperidone. Pharmacotherapy 1997; 17: 617–621
   PubMed Web of Science ®Google Scholar
• Burkhard P. R., Vingerhoets F. L.G. Olanzapine-Induced Neuroleptic Malignant Syndrome (letter). Arch. Gen. Psychiatr. 1999; 56: 101–102
   PubMed Web of Science ®Google Scholar
• Hummer M., Kurz M., Kurzthalaer I., Oberbauer H., Miller C., Fleischhacker W. W. Hepatotoxicity of Clozapine. J. Clin. Psychopharmacol. 1997; 17: 314–317
   PubMed Web of Science ®Google Scholar
• Whitworth A. B., Liensberger D., Fleischhacker W. W. Transient Increase of Liver Enzymes Induced by Risperidone: Two Case Reports (letter). J. Clin. Psychopharmacol. 1999; 19: 475–476
   PubMed Web of Science ®Google Scholar
• Kellner M., Wiedemann K., Krieg J. C., Berg P. Toxic Hepatitis by Clozapine Treatment. Am. J. Psychol. 1993; 150: 985–986
   Web of Science ®Google Scholar
• Fuller M. A., Simon M. R., Freedman L. Risperidone-Associated Hepatotoxicity (letter). J. Clin. Psychopharmacol. 1996; 16: 84–85
   PubMed Web of Science ®Google Scholar
• Alvir J., Lieberman J., Safferman A., Schwimmer J. L., Schaaf J. A. Clozapine-Induced Agranulocytosis: Incidence and Risk Factors in the United States. N. Engl. J. Med. 1993; 329: 162–167
   PubMed Web of Science ®Google Scholar
• Safferman A., Lieberman J. A., Kane J. M., Szymanski S., Kinon B. Update on the Clinical Efficacy and Side Effects of Clozapine. Schizophr. Bull. 1991; 17: 247–261
   PubMed Web of Science ®Google Scholar
• Geibig C. B., Marks L. W. Treatment of Clozapine- and Molindone-Induced Agranulocytosis with Granulocyte Colony-Stimulating Factor. Ann. Pharmacotherapy 1993; 27: 1190–1194
   PubMed Web of Science ®Google Scholar
• Anonymous. Clozapine and Myocarditis WHO Drug Information 1994; 8: 212–213
   Google Scholar
• Goff D. C., Baldessarini R. J. Drug Interactions with Antipsychotic Agents. J. Clin. Psychopharmacol. 1993; 13: 57–67
   PubMed Web of Science ®Google Scholar
• Edge S. C., Markowitz J. S., DeVane C. L. Clozapine Drug Interactions: A Review of the Literature. Hum. Psychopharmacol. 1997; 12: 5–20
   Web of Science ®Google Scholar
• Klimke A., Klieser E. Sudden Death After Intra-venous Application of Lorazepam in a Patient Treatedwith Clozapine (letter). Am. J. Psychiatry 1994; 151: 780
   PubMed Web of Science ®Google Scholar
• Tanaka E., Hisawa S. Clinically Significant Pharmacokinetic Drug Interactions with Psychoactive Drugs: Antidepressants and Antipsychotics and the Cytochrome P450 System. J. Clin. Pharm. Therapeutics 1999; 24: 7–16
   PubMed Web of Science ®Google Scholar
• Taylor D. Pharmacokinetic Interactions Involving Clozapine. Br. J. Psychiatry 1997; 171: 109–112
   PubMed Web of Science ®Google Scholar
• Cohen L. G., Chesley S., Eugenio L., Flood J. G., Fisch J., Goff D. C. Erythromycin-Induced Clozapine Toxic Reaction. Arch. Int. Med. 1996; 156: 675–677
   PubMed Web of Science ®Google Scholar
• Funderburg L. G., Vertrees J. E., True J. E., Miller A. L. Seizure Following Addition of Erythromycin to Clozapine Treatment. Am. J. Psychiatr. 1994; 151: 1840–1841
   PubMed Web of Science ®Google Scholar
• Sloan K. L., Haver V. M., Saxon A. J. Quetiapine and False-Positive Urine Drug Testing for Tricyclic Antidepressants (letter). Am. J. Psychiatr. 2000; 157: 148–149
   PubMed Web of Science ®Google Scholar
• Burns M. J., Linden C. H., Graudins A., Brown R. M., Fletcher K. E. A Comparison of Physostigmine and Benzodiazepines for the Treatment of Anticholinergic Poisoning. Ann. Emerg. Med. 2000; 35: 374–381
   PubMed Web of Science ®Google Scholar
• American Academy of Clinical Toxicology, European Association of Poisons Centres and Clinical Toxicologists. Position Statement: Single-Dose Activated Charcoal. J. Toxicol. Clin. Toxicol. 1997; 35: 721–741
   PubMed Web of Science ®Google Scholar